Updated time: 2022-08-24 14:41:41
11A-1080617
TW I774099、US Patent filing
IgA nephropathy (IgAN) is the most common cause of glomerulonephritis in the worldwide. The diagnosis of IgAN is still characterized by clinical characterization and invasive surgery, to collection renal tissue to confirm the lesion. Previous studies have shown that IgAN is closely related to the abnormality of O-glycosylation of galactose-deficiency in immunoglobulin。Here, we develop a novel analytical method using lectin CGL (Crenomytilus grayanus) from one of the marine mussels, specific for N-acetyl-2-deoxy-2-amino-galactose (GalNAc/ Gal). The affinity and binding ability has successfully developed a novel Gd-IgA1 detection method.
- Non-invasive diagnostic.
- Novel Gd-IgA1 detection method, that detects Gd-IgA1 in serum specific.
- Diagnostic IgA nephropathy.
- Non-invasive IgA nephropathy diagnostic.
- Purified Gd-IgA.
Ann Chen, Shuk-Man Ka, Shih-Hsiung Wu
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Development of diagnostic reagents using Crenomytilus grayanus Lectin for IgA nephropathy